These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 8706016

  • 1. Augmentation of antitumor immunity with bacterial superantigen, staphylococcal enterotoxin B-bound tumor cells.
    Shimizu M, Yamamoto A, Nakano H, Matsuzawa A.
    Cancer Res; 1996 Aug 15; 56(16):3731-6. PubMed ID: 8706016
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
    Shu S, Krinock RA, Matsumura T, Sussman JJ, Fox BA, Chang AE, Terman DS.
    J Immunol; 1994 Feb 01; 152(3):1277-88. PubMed ID: 8301131
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response.
    Lussow AR, MacDonald HR.
    Eur J Immunol; 1994 Feb 01; 24(2):445-9. PubMed ID: 8299694
    [Abstract] [Full Text] [Related]

  • 4. Acquired resistance to superantigen-induced T cell shock. V beta selective T cell unresponsiveness unfolds directly from a transient state of hyperreactivity.
    Miethke T, Wahl C, Heeg K, Wagner H.
    J Immunol; 1993 May 01; 150(9):3776-84. PubMed ID: 8473732
    [Abstract] [Full Text] [Related]

  • 5. Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin-2 pathway.
    Gonzalo JA, Moreno de Alborán I, Alés-Martínez JE, Martínez C, Kroemer G.
    Eur J Immunol; 1992 Apr 01; 22(4):1007-11. PubMed ID: 1551401
    [Abstract] [Full Text] [Related]

  • 6. Differential effect of staphylococcal enterotoxin B upon the induction of tolerance on peripheral CD4+V beta 8+ and CD8+V beta 8+ T cells.
    Sabapathy TK, Hwang LA, Hui KM.
    Cell Immunol; 1994 Oct 01; 158(1):83-95. PubMed ID: 7916268
    [Abstract] [Full Text] [Related]

  • 7. In vivo tumor immunotherapy by a bacterial superantigen.
    Ochi A, Migita K, Xu J, Siminovitch K.
    J Immunol; 1993 Sep 15; 151(6):3180-6. PubMed ID: 8376773
    [Abstract] [Full Text] [Related]

  • 8. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
    Kuroda K, Yagi J, Imanishi K, Yan XJ, Li XY, Fujimaki W, Kato H, Miyoshi-Akiyama T, Kumazawa Y, Abe H, Uchiyama T.
    J Immunol; 1996 Aug 15; 157(4):1422-31. PubMed ID: 8759722
    [Abstract] [Full Text] [Related]

  • 9. Superantigen-induced anergy of V beta 8+ CD4+ T cells induces functional but non-proliferative T cells in vivo.
    Gaus H, Miethke T, Wagner H, Heeg K.
    Immunology; 1994 Nov 15; 83(3):333-40. PubMed ID: 7835956
    [Abstract] [Full Text] [Related]

  • 10. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
    Muraille E, De Smedt T, Andris F, Pajak B, Armant M, Urbain J, Moser M, Leo O.
    J Immunol; 1997 Mar 15; 158(6):2638-47. PubMed ID: 9058796
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of peripheral T cell deletion: anergized T cells are Fas resistant but undergo proliferation-associated apoptosis.
    Miethke T, Vabulas R, Bittlingmaier R, Heeg K, Wagner H.
    Eur J Immunol; 1996 Jul 15; 26(7):1459-67. PubMed ID: 8766547
    [Abstract] [Full Text] [Related]

  • 12. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
    Surman S, Deckhut AM, Blackman MA, Woodland DL.
    J Immunol; 1994 May 15; 152(10):4893-902. PubMed ID: 8176210
    [Abstract] [Full Text] [Related]

  • 13. Differential in vivo effects of a superantigen and an antibody targeted to the same T cell receptor. Activation-induced cell death vs passive macrophage-dependent deletion.
    Gonzalo JA, Baixeras E, González-García A, George-Chandy A, Van Rooijen N, Martínez C, Kroemer G.
    J Immunol; 1994 Feb 15; 152(4):1597-608. PubMed ID: 8120373
    [Abstract] [Full Text] [Related]

  • 14. Clonal anergy to staphylococcal enterotoxin B in vivo: selective effects on T cell subsets and lymphokines.
    Baschieri S, Lees RK, Lussow AR, MacDonald HR.
    Eur J Immunol; 1993 Oct 15; 23(10):2661-6. PubMed ID: 8104798
    [Abstract] [Full Text] [Related]

  • 15. Studies of T cell deletion and T cell anergy following in vivo administration of SEB to normal and lupus-prone mice.
    Scott DE, Kisch WJ, Steinberg AD.
    J Immunol; 1993 Jan 15; 150(2):664-72. PubMed ID: 8419493
    [Abstract] [Full Text] [Related]

  • 16. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
    Wen R, Blackman MA, Woodland DL.
    J Immunol; 1995 Aug 15; 155(4):1884-92. PubMed ID: 7636239
    [Abstract] [Full Text] [Related]

  • 17. Staphylococcal enterotoxin B induces arthritis in female DBA/1 mice but fails to induce activation of type II collagen-reactive lymphocytes.
    Omata S, Sasaki T, Kakimoto K, Yamashita U.
    Cell Immunol; 1997 Aug 01; 179(2):138-45. PubMed ID: 9268497
    [Abstract] [Full Text] [Related]

  • 18. Pertussis toxin interferes with superantigen-induced deletion of peripheral T cells without affecting T cell activation in vivo. Inhibition of deletion and associated programmed cell death depends on ADP-ribosyltransferase activity.
    Gonzalo JA, González-García A, Baixeras E, Zamzami N, Tarazona R, Rappuoli R, Martínez C, Kroemer G, Tarazona R, Terezone R.
    J Immunol; 1994 May 01; 152(9):4291-9. PubMed ID: 7908917
    [Abstract] [Full Text] [Related]

  • 19. Administration of recombinant human IL-1 by Staphylococcus enterotoxin B prevents tolerance induction in vivo.
    Nakata Y, Matsuda K, Uzawa A, Nomura M, Akashi M, Suzuki G.
    J Immunol; 1995 Nov 01; 155(9):4231-5. PubMed ID: 7594579
    [Abstract] [Full Text] [Related]

  • 20. Administration of superantigens protects mice from lethal Listeria monocytogenes infection by enhancing cytotoxic T cells.
    Okamoto S, Kawabata S, Nakagawa I, Hamada S.
    Infect Immun; 2001 Nov 01; 69(11):6633-42. PubMed ID: 11598032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.